Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study.
Syrios J1,
Kouroussis C1,
Kotsakis A1,
Kentepozidis N1, Kontopodis E1,
Kalbakis K1,
Vardakis N1,
Hatzidaki D1,
Polyzos A1,
Georgoulias V2;
GU Working Group of the Hellenic Oncology Research Group (HORG), Athens, Greece.
Efficacy of panitumumab in older patients with metastatic colorectal cancer: a retrospective analysis using the database of the Hellenic Oncology Research Group (HORG)
Asimakopoulou N, Souglakos J, Kentepozidis N, Karampeazis A, Kotsakis A, Ziras N, Makrantonakis P, Prinarakis E, Vamvakas L, Georgoulias V
Efficacy of panitumumab in older patients with metastatic colorectal cancer: a retrospective analysis using the database of the Hellenic Oncology Research Group (HORG)
ISO-CC-005; a phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer
G. Carlsson, T.K. Guren, J. Haux, P. Pfeiffer, H. Taflin1, D. Mavroudis, V. Georgoulias, C. Papadimitriou, N. Kentepozidis, D. Boumpas, L. Skintemo1, K. Ganlöv, B. Gustavsson
Three versus six months adjuvant FOLFOX or CAPOX for high risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant chemotherapy…
